Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GM2?

Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GM2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GM2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GM2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GM2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GM2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GM2?

Disease model

Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GM2

Download all related citations
Per page 10 20 50 100 | Total 558
Authors Title Published Journal PubMed Link
pmid:14766311
Schwerer B et al. Antisera against ganglioside GM2: immunochemical and immunohistological studies. Neuropathol. Appl. Neurobiol. pmid:6214725
Sakuraba H et al. Prenatal diagnosis of GM2-gangliosidosis. Immunofluorescence analysis of ganglioside GM2 in cultured amniocytes by confocal laser scanning microscopy. Brain Dev. pmid:8250149
Mikami M et al. Characteristic alteration in the concentration of IV 3NeuAc alpha-nLc4Cer in the villi of human placenta during the gestational period. Placenta pmid:8248034
pmid:11495348
Boggs JM et al. Immune lysis of lipid vesicles containing myelin basic protein or glycolipid antigens by multiple sclerosis and normal sera. J. Neurol. Sci. pmid:6085112
Rockwell HE et al. AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system. ASN Neuro pmid:25873306
McIntyre C et al. Correction of murine mucopolysaccharidosis type IIIA central nervous system pathology by intracerebroventricular lentiviral-mediated gene delivery. J Gene Med pmid:25418946
Kroll RA et al. White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities. AJNR Am J Neuroradiol pmid:7677013
pmid:
Dotta F et al. Autoantigens in type 1 diabetes mellitus. J. Endocrinol. Invest. pmid:7829824
pmid:8120069
pmid:19559406
Arai M and Kusunoki S [A case of multifocal motor neuropathy with IgM lambda anti-GM1 antibody and IgM kappa paraprotein reacting exclusively with GM2]. Rinsho Shinkeigaku pmid:19348179
Caudie C et al. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Ann. Biol. Clin. (Paris) pmid:10518060
pmid:18473163
SAIFER A et al. CHROMATOGRAPHIC STUDIES OF NORMAL AND TAY-SACHS GANGLIOSIDES (PEPTIDE-STRANDIN). 1963 J. Neurochem. pmid:14062003
Volk BW et al. The gangliosidoses. 1975 Hum. Pathol. pmid:170187
Op Den Velde W and Hooghwinkel GJ The brain ganglioside pattern in presenile and senile dementia. 1975 J Am Geriatr Soc pmid:1141629
Holmgren J et al. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. 1975 Proc. Natl. Acad. Sci. U.S.A. pmid:1058471
Molzer B and Bernheimer H Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay. 1976 Clin. Chim. Acta pmid:826357
Purpura DP and Suzuki K Distortion of neuronal geometry and formation of aberrant synapses in neuronal storage disease. 1976 Brain Res. pmid:824017
Kemp SF and Stoolmiller AC Studies on the biosynthesis of glyco-sphingolipids in cultured mouse neuroblastoma cells: characterization and acceptor specificities of N-acetylneuraminyl- and N-acetylgalactosaminyltransferases. 1976 J. Neurochem. pmid:823300
Hoffman LM et al. GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease. 1976 Brain Res. pmid:953690
Itaya K and Hakomori S Gangliosides and 'galactoprotein A' ('LETS'-protein) of temperature-sensitive mutant of transformed 3T3 cells. 1976 FEBS Lett. pmid:179896
Pierce KR et al. Animal model of human disease: GM2 gangliosidosis. 1976 Am. J. Pathol. pmid:817606
Rapin I et al. Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship. 1976 Arch. Neurol. pmid:175770
Kemp SF and Stoolmiller AC Biosynthesis of glycosphingolipids in cultured mouse neuroblastoma cells. Precursor-product relationships among sialoglycosphingolipids. 1976 J. Biol. Chem. pmid:1033935
Hechtman P and LeBlanc D Purification and properties of the hexosaminidase A-activating protein from human liver. 1977 Biochem. J. pmid:603630
Hoffman LM et al. Glycosphingolipids in fetal Tay-Sachs disease brain and lung cultures. 1977 J. Neurochem. pmid:894310
Bernheimer H et al. Sandhoff disease: ganglioside G(M2) and asialo-G(M2) accumulation in the cerebrospinal fluid. 1977 J. Neurochem. pmid:407331
Duffard RO et al. Ganglioside composition and biosynthesis in cultred cells derived from CNS. 1977 J. Neurochem. pmid:406360
Cork LC et al. GM2 ganglioside lysosomal storage disease in cats with beta-hexosaminidase deficiency. 1977 Science pmid:404709
Ciesielski-Treska J et al. Gangliosides of active and inactive neuroblastoma clones. 1977 Differentiation pmid:202531
O'Brien JS et al. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts. 1977 Clin. Genet. pmid:13950
Geiger B and Smolarsky M Immunochemical determination of ganglioside GM2, by inhibition of complement-dependent liposome lysis. 1977 J. Immunol. Methods pmid:333030
O'Brien JS et al. Characterization of unusual hexosaminidase A (HEX A) deficient human mutants. 1978 Am. J. Hum. Genet. pmid:747188
O'Neill B et al. Adult-onset GM2 gangliosidosis. Seizures, dementia, and normal pressure hydrocephalus associated with glycolipid storage in the brain and arachnoid granulation. 1978 Neurology pmid:568730
Kosanke SD et al. Clinical and biochemical abnormalities in porcine GM2-gangliosidosis. 1978 Vet. Pathol. pmid:108843
Conzelmann E and Sandhoff K AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. 1978 Proc. Natl. Acad. Sci. U.S.A. pmid:99746
Young WW et al. Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2). 1979 J. Exp. Med. pmid:512581
O'Brien JS and Geiger B Normal adult with absent HEX A: immunoreactive HEX A is present. 1979 Am. J. Hum. Genet. pmid:507054
Novak A et al. Preparation of radiolabeled GM2 and GA2 gangliosides. 1979 J. Lipid Res. pmid:490046
Li SC et al. Evidence for the presence of two separate protein activators for the enzymic hydrolysis of GM1 and GM2 gangliosides. 1979 J. Biol. Chem. pmid:115863
Hadfield MG et al. Pathologic findings in mucopolysaccharidosis type IIIB (Sanfilippo's sydnrome B). 1980 Arch. Neurol. pmid:6775621
Suzuki Y et al. Action of ortho- and paramyxovirus neuraminidase on gangliosides. Hydrolysis of ganglioside GM1 by Sendai virus neuraminidase. 1980 Biochim. Biophys. Acta pmid:6257300
Johnson WG et al. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies. 1980 Am. J. Hum. Genet. pmid:6772023
Hechtman P and Kachra Z Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside. 1980 Biochem. J. pmid:7387624
Hoffman LM et al. Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase A. 1980 J. Neurosci. Res. pmid:7441795
Holmgren J et al. Polystyrene-adsorbed gangliosides for investigation of the structure of the tetanus-toxin receptor. 1980 Eur. J. Biochem. pmid:7398619
Erzberger A et al. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis. 1980 Clin. Chim. Acta pmid:6781795
Chien JL and Hogan EL Characterization of two gangliosides of the paragloboside series from chicken skeletal muscle. 1980 Biochim. Biophys. Acta pmid:7236652
Hoffman LM et al. Human fetal brain cells in culture. Increase in GM2 ganglioside after SV-40 transformation. 1981 Biochim. Biophys. Acta pmid:6271225
Li SC et al. A new variant of type-AB GM2-gangliosidosis. 1981 Biochem. Biophys. Res. Commun. pmid:7306091
Pullarkat RK et al. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis. 1981 Pediatrics pmid:7243492
Li SC et al. A protein activator for the enzymic hydrolysis of GM2 ganglioside. 1981 J. Biol. Chem. pmid:7240201
Watanabe T et al. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. 1982 J. Exp. Med. pmid:7175442
Hasilik A et al. Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. 1982 Eur. J. Biochem. pmid:6214395
Poulos A et al. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate. 1982 Clin. Chim. Acta pmid:6210469
Conzelmann E et al. Complexing of glycolipids and their transfer between membranes by the activator protein for degradation of lysosomal ganglioside GM2. 1982 Eur. J. Biochem. pmid:6210531
Hashimoto Y et al. The occurrence of GM4 and GM2 in erythrocytes from inbred strains of mice. 1982 J. Biochem. pmid:7076644
Riedl M et al. A ganglioside-dependent cellular binding mechanism in rat macrophages. 1982 J. Immunol. pmid:7073871
Yu RK et al. Characterization of some minor gangliosides in Tay-Sachs brains. 1983 Brain Res. pmid:6414648
Kniep B et al. Gangliotriaosylceramide (asialo GM2), a glycosphingolipid marker for cell lines derived from patients with Hodgkin's disease. 1983 J. Immunol. pmid:6886427
Conzelmann E et al. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level. 1983 Am. J. Hum. Genet. pmid:6614006
Tai T et al. Ganglioside GM2 as a human tumor antigen (OFA-I-1). 1983 Proc. Natl. Acad. Sci. U.S.A. pmid:6193515
Yusuf HK et al. Ganglioside biosynthesis in Golgi apparatus of rat liver. Stimulation by phosphatidylglycerol and inhibition by tunicamycin. 1983 Eur. J. Biochem. pmid:6861762
Inui K et al. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein. 1983 Am. J. Hum. Genet. pmid:6224417
Li YT et al. Differentiation of two variants of type-AB GM2-gangliosidosis using chromogenic substrates. 1983 Am. J. Hum. Genet. pmid:6222647
Hashimoto Y et al. Genetic regulation of GM2 expression in liver of mouse. 1983 J. Biochem. pmid:6874670
Kaplan F and Hechtman P Purification and properties of two enzymes catalyzing galactose transfer to GM2 ganglioside from rat liver Golgi. 1983 J. Biol. Chem. pmid:6401719
Hirabayashi Y et al. The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis. 1983 J. Neurochem. pmid:6848657
Young WW et al. Decreased glycolipid antigen expression in lymphoma cell variants escaping from anti-glycolipid serotherapy. 1983 J. Exp. Med. pmid:6848617
Harzer K Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses. 1983 Clin. Chim. Acta pmid:6228344
Seyfried TN et al. Cellular distribution of gangliosides in the developing mouse cerebellum: analysis using the staggerer mutant. 1984 J. Neurochem. pmid:6470710
Sandhoff K and Conzelmann E The biochemical basis of gangliosidoses. 1984 Neuropediatrics pmid:6242704
Goebel HH Morphology of the gangliosidoses. 1984 Neuropediatrics pmid:6100800
Di Gregorio F et al. The influence of gangliosides on neurite growth and regeneration. 1984 Neuropediatrics pmid:6100799
Pampiglione G and Harden A Neurophysiological investigations in GM1 and GM2 gangliosidoses. 1984 Neuropediatrics pmid:6100798
Schulte FJ Clinical course of GM2 gangliosidoses. A correlative attempt. 1984 Neuropediatrics pmid:6100797
Li YT et al. Isolation and characterization of a novel phytosphingosine-containing GM2 ganglioside from mullet roe (Mugil cephalus). 1984 J. Biol. Chem. pmid:6746635
Schwab ME and Vassella F Synopsis: gangliosidoses. 1984 Neuropediatrics pmid:6100793
Meek D et al. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis. 1984 Ann. Neurol. pmid:6430210
Scheideler MA et al. Cell-cycle dependence of a ganglioside glycosyltransferase activity and its inhibition by enkephalin in a neurotumor cell line. 1984 J. Neurochem. pmid:6422000
Itoh H et al. The fine structure of cytoplasmic inclusions in brain and other visceral organs in Sandhoff disease. 1984 Brain Dev. pmid:6097133
Kadowaki H et al. Separation of brain monosialoganglioside molecular species by high-performance liquid chromatography. 1984 J. Lipid Res. pmid:6512419
Fishman PH et al. The role of gangliosides in the interaction of human chorionic gonadotropin and cholera toxin with murine Leydig tumor cells. 1984 J. Biol. Chem. pmid:6330091
Li SC et al. Effect of modification of sialic acid on enzymic hydrolysis of gangliosides GM1 and GM2. 1984 J. Biol. Chem. pmid:6232275
Nojiri H et al. Characteristic expression of glycosphingolipid profiles in the bipotential cell differentiation of human promyelocytic leukemia cell line HL-60. 1984 Blood pmid:6589019
Berry-Kravis E and Dawson G Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor. 1985 J. Neurochem. pmid:2997394
Raghavan SS et al. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures. 1985 Am. J. Hum. Genet. pmid:2934978
Ishizuka I et al. Preparation and enzymatic degradation of monosulfogangliotriaosylceramide. 1985 J. Biol. Chem. pmid:3928630
Sasaki T Glycolipid-binding proteins. 1985 Chem. Phys. Lipids pmid:4064224
Higashi H et al. Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. 1985 Cancer Res. pmid:3874688
Iwamori M et al. Brain gangliosides of quaking and shiverer mutants: qualitative and quantitative changes of monosialogangliosides in the quaking brain. 1985 J. Neurochem. pmid:3998734
Burg J et al. Mapping of the gene coding for the human GM2 activator protein to chromosome 5. 1985 Ann. Hum. Genet. pmid:3865618
Navon R et al. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A. 1985 Am. J. Hum. Genet. pmid:3156493
Wenger DA Diagnosis of atypical patients with lipid storage diseases. 1985 Brain Dev. pmid:4014607
Li SC et al. Activator protein required for the enzymatic hydrolysis of cerebroside sulfate. Deficiency in urine of patients affected with cerebroside sulfatase activator deficiency and identity with activators for the enzymatic hydrolysis of GM1 ganglioside and globotriaosylceramide. 1985 J. Biol. Chem. pmid:2981875
Wood PA et al. Fluorescence polarization analysis, lipid composition, and Na+, K+-ATPase kinetics of synaptosomal membranes in feline GM1 and GM2 gangliosidosis. 1985 J. Neurochem. pmid:2983023